Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Vaccination against acute otitis media].

R H Veenhoven1, Y L van den Berg, A G Schilder

  • 1Spaarne Ziekenhuis, afd. Kindergeneeskunde, BR Haarlem.

Nederlands Tijdschrift Voor Geneeskunde
|May 29, 2000
PubMed
Summary

Preventing childhood acute otitis media (AOM) is crucial due to high illness rates and antibiotic resistance. Pneumococcal conjugate vaccines reduce some AOM cases, especially for children with recurrent ear infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serologic response to a third dose of an mRNA-based SARS-CoV-2 vaccine in lung transplant recipients.

Transplant immunology·2022
Same author

Corrigendum to 'Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL' [Journal of Clinical Virology 141 (2021) 104909].

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2021
Same author

Poor Serologic Response to 2 Doses of an mRNA-based SARS-CoV-2 Vaccine in Lung Transplant Recipients.

Transplantation·2021
Same author

Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2021
Same author

Pneumococcal vaccination in lung transplant patients.

Expert review of vaccines·2020
Same author

Migration and tuberculosis in Europe.

Journal of clinical tuberculosis and other mycobacterial diseases·2020

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Vaccinology

Context:

  • Acute otitis media (AOM) is the most common bacterial infection in children.
  • Rising antibiotic resistance in Streptococcus pneumoniae, a primary AOM pathogen, necessitates prevention strategies.
  • High morbidity and healthcare costs associated with AOM underscore the need for effective interventions.

Purpose:

  • To evaluate the impact of pneumococcal conjugate vaccines on the incidence of acute otitis media.
  • To assess the effectiveness of vaccination in preventing AOM, particularly in children with recurrent infections.

Summary:

  • Pneumococcal conjugate vaccines decrease AOM cases linked to vaccine serotypes.
  • Overall AOM incidence reduction is less than 10% despite vaccination.

Related Experiment Videos

  • Children experiencing recurrent AOM episodes may derive greater benefit from these vaccines.

    • Impact:

    • Vaccination strategies can help mitigate the burden of AOM in pediatric populations.
    • Further research may be needed to enhance vaccine efficacy against non-vaccine serotypes and overall AOM prevention.
    • Understanding vaccine impact on recurrent AOM is key for targeted public health initiatives.